This media is not supported in your browser
VIEW IN TELEGRAM
US coverage on Iran in a nutshell: different faces, near-identical scripts.
"Short-term pain for the long-term gain."
(Hatsoff)
"Short-term pain for the long-term gain."
(Hatsoff)
The companies called it a “landmark moment”—the first successful late-stage trial of an mRNA-based cancer treatment. News reports heralded a breakthrough. Elon Musk even declared that “synthetic RNA will cure many diseases.”
No Phase III results have been published in the peer-reviewed literature, and none have been posted (https://clinicaltrials.gov/study/NCT05933577?tab=results) to ClinicalTrials.gov.
Instead, all the excitement rests on a company press release.
https://blog.maryannedemasi.com/p/modernas-melanoma-breakthrough-is
No Phase III results have been published in the peer-reviewed literature, and none have been posted (https://clinicaltrials.gov/study/NCT05933577?tab=results) to ClinicalTrials.gov.
Instead, all the excitement rests on a company press release.
https://blog.maryannedemasi.com/p/modernas-melanoma-breakthrough-is
Maryannedemasi
Moderna’s melanoma ‘breakthrough’ is still science by press release
Everyone is celebrating a Phase III breakthrough in personalised mRNA cancer treatment—except nobody outside the companies has seen the data.
🗿1
The Israeli company Toka sells technologies that allow clients to locate security cameras or even webcams within a given perimeter, hack into them, watch their live feed and even alter it – and past recordings.
Toka was co-founded by former Israeli premier Ehud Barak together with the former Israel Defense Forces cyber chief Brig. Gen. (ret.) Yaron Rosen
https://archive.md/JSmD4#selection-875.91-875.291
Toka was co-founded by former Israeli premier Ehud Barak together with the former Israel Defense Forces cyber chief Brig. Gen. (ret.) Yaron Rosen
https://archive.md/JSmD4#selection-875.91-875.291
archive.li
Revealed: The Israeli Firm Selling ‘Dystopian’ Hacking Capabilities -…
archived 23 Dec 2022 04:33:33 UTC
🤯3👀2